Center-Authored Papers

Filters: Author is Crawford, J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J et al..  2006.  EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.. European journal of cancer (Oxford, England : 1990). 42(15):2433-53. Abstract
C
Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G.  1991.  Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.. The New England journal of medicine. 325(3):164-70. Abstract
L
Lyman GH, Reiner M, Morrow PK, Crawford J.  2015.  The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy.. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. Abstract
Lyman GH, Dale DC, Culakova E, Poniewierski MS, Wolff DA, Kuderer NM, Huang M, Crawford J.  2013.  The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials.. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 24(10):2475-84. Abstract